Serum Marker/Blood Test
Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk
Mutation Research. 2008 Jun 27. [Epub ahead of print] [Link] Amati M, Tomasetti M, Mariotti L, Tarquini LM, Valentino M, Santarelli L. Department of Molecular Pathology and Innovative Therapies, Institute of Occupational Medicine, Polytechnic University of Marche, Ancona, Italy. Abstract Epidemiological studies have shown that mortality from malignant mesothelioma (MM) and lung cancer have increased…
Read MoreSoluble Mesothelin Related Protein (SMRP) in an Asbestos Exposed Population
American Journal of Respiratory and Critical Care Medicine.. 2008 Jun 26. [Epub ahead of print] [Link] Park EK, Sandrini A, Yates DH, Thomas PS, Creaney J, Robinson BW, Johnson AR. Research and Education Unit, Dust Diseases Board, Sydney, NSW, Australia. Abstract Rationale: Soluble mesothelin related protein (SMRP) is raised in epithelial type malignant mesothelioma (MM),…
Read MoreCoalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure
Pathology International. 2008 Jul;58(7):451-5. [Link] Tsuzuki T, Ninomiya H, Natori Y, Ishikawa Y. Department of Pathology, Nagoya Daini Red Cross Hospital, Nagoya, Japan. Abstract Coexistence of pulmonary adenocarcinoma and pleural malignant mesothelioma is extremely rare, although both are asbestos-related. Herein is presented a rare case of coalescent lung tumor made up of a malignant mesothelioma…
Read MoreImmunophenotyping of serous carcinoma of the female genital tract
Modern Pathology. 2008 Jun 20. [Epub ahead of print] [Link] Nofech-Mozes S, Khalifa MA, Ismiil N, Saad RS, Hanna WM, Covens A, Ghorab Z. 1Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. Abstract To update the data on the expression of ‘mesothelioma markers’ by serous carcinomas of various sites…
Read MorePrognostic role of osteopontin expression in malignant pleural mesothelioma
American Journal of Clinical Pathology. 2008 Jul;130(1):58-64. [Link] Cappia S, Righi L, Mirabelli D, Ceppi P, Bacillo E, Ardissone F, Molinaro L, Scagliotti GV, Papotti M. Department of Clinical and Biological Sciences, University of Torino at St Luigi Hospital, Torino, Italy. Abstract Malignant pleural mesothelioma (MPM) represents highly aggressive neoplasms with a mean survival of…
Read MoreUroplakin is not a Reliable Immunohistochemical Marker for Malignant Mesothelioma of the Pleura
Applied immunohistochemistry & molecular morphology. 2008 Jun 3. [Epub ahead of print] [Link] Butnor KJ, Ordonez NG. *The University of Vermont, Burlington, VT †M.D. Anderson Cancer Center, Houston, TX. Abstract Aim: To analyze the immunohistochemical expression of uroplakin (URO) in pleural malignant mesothelioma (PMM). Methods and Results: We analyzed URO expression in PMM using similar…
Read MoreMalignant mesothelioma 2008
Current Opinion in Pulmonary Medicine. 14(4):303-309, July 2008. [Link] Zervos MD, Bizekis C, Pass HI. Department of Cardiothoracic Surgery, Division of Thoracic Surgery, New York University School of Medicine, New York, USA. zervom01@med.nyu.edu Abstract Purpose of review: Mesothelioma is an aggressive malignancy of the pleura with poor survival. There will be approximately 3000 cases of…
Read MoreOverexpression and altered glycosylation of MUC1 in malignant mesothelioma
Molecular Diagnostics. 2008 May 6;98(9):1562-9. Epub 2008 Apr 29. [Link] Creaney J, Segal A, Sterrett G, Platten MA, Baker E, Murch AR, Nowak AK, Robinson BW, Millward MJ. National Research Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, University of Western Australia, Perth, Western Australia, Australia. creaneyj@cyllene.uwa.edu.au Abstract Current interest in the…
Read MoreEvaluation of a series of serum mesothelin in patients with pleural malignant mesothelioma
Giornale Italiano di Medicina del Lavoro ed Ergonomia. 2007 Jul-Sep;29(3 Suppl):339-42. [Link] Simonini S, Foddis R, Filiberti R, Puntoni R, Mutti L, Ambrosino N, Chella A, Guglielmi G, Buselli R, Iuzzolini M, Mignani A, Ottenga F, Cristaudo A. U.O. Medicina Preventiva del Lavoro, Azienda Ospedeliero- Universitaria Pisana. Abstract Pleural Malignant Mesothelioma (MM) is a highly…
Read MoreSerum mesothelin dosages in follow-up of previously exposed workers
Giornale Italiano di Medicina del Lavoro ed Ergonomia. 2007 Jul-Sep;29(3 Suppl):342-5. [Link] Foddis R, Vivaldi A, Filiberti R, Puntoni R, Mutti L, Ambrosino N, Chella A, Guglielmi G, Gattini V, Buselli R, Perretta S, Cristaudo A. Dipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Università di Pisa. r.foddis@med.unipi.it Abstract High dosages of…
Read More